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Abstract
Background: The polycomb-group (PcG) proteins function as general regulators of stem cells. We previously reported that
retrovirus-mediated overexpression of Bmi1, a gene encoding a core component of polycomb repressive complex (PRC) 1,
maintained self-renewing hematopoietic stem cells (HSCs) during long-term culture. However, the effects of overexpression
of Bmi1 on HSCs in vivo remained to be precisely addressed.
Methodology/Principal findings: In this study, we generated a mouse line where Bmi1 can be conditionally overexpressed
under the control of the endogenous Rosa26 promoter in a hematopoietic cell-specific fashion (Tie2-Cre;R26Stop
FLBmi1).
Although overexpression of Bmi1 did not significantly affect steady state hematopoiesis, it promoted expansion of
functional HSCs during ex vivo culture and efficiently protected HSCs against loss of self-renewal capacity during serial
transplantation. Overexpression of Bmi1 had no effect on DNA damage response triggered by ionizing radiation. In contrast,
Tie2-Cre;R26Stop
FLBmi1 HSCs under oxidative stress maintained a multipotent state and generally tolerated oxidative stress
better than the control. Unexpectedly, overexpression of Bmi1 had no impact on the level of intracellular reactive oxygen
species (ROS).
Conclusions/Significance: Our findings demonstrate that overexpression of Bmi1 confers resistance to stresses, particularly
oxidative stress, onto HSCs. This thereby enhances their regenerative capacity and suggests that Bmi1 is located
downstream of ROS signaling and negatively regulated by it.
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Introduction
Hematopoietic stem cells (HSCs) are defined as primitive cells
that are capable of both self-renewal and differentiation into any of
the hematopoietic cell lineages. Cell fate decisions of HSCs (self-
renewal vs. differentiation) are precisely regulated to maintain
their numbers and lifespan. Defects in these processes lead to
hematopoietic insufficiencies and to the development of hemato-
poietic malignancies.
The polycomb-group (PcG) proteins play key roles in the
initiation and maintenance of gene silencing through histone
modifications. PcG proteins belong to two major complexes,
Polycomb repressive complex 1 and 2 (PRC1 and PRC2). PRC1
monoubiquitylates histone H2A at lysine 119 and PRC2
trimethylates histone H3 at lysine 27 [1]. Of note, PcG proteins
have been implicated in the maintenance of self-renewing stem
cells [2–4]. Among PcG proteins, Bmi1, a core component of
PRC1, plays an essential role in the maintenance of self-renewal
ability of HSCs at least partially by silencing the Ink4a/Arf locus
[5–8]. Bmi1 also maintains multipotency of HSCs by keeping
developmental regulator gene promoters poised for activation [9].
Furthermore, Bmi1 has been implicated in the maintenance of the
proliferative capacity of leukemic stem cells [5]. Consistent with
these findings, levels of BMI1 expression in the human CD34
+ cell
fraction have been reported to correlate well with the progression
and prognosis of myelodysplastic syndrome and chronic and acute
myeloid leukemia [4,10], suggesting a role of BMI1 in leukemic
stem cells.
We previously reported that overexpression of Bmi1 using a
retrovirus maintains self-renewal capacity of HSCs and markedly
expands multipotent progenitors ex vivo, resulting in an enhance-
ment of repopulating capacity of HSCs after culture. Likewise,
forced expression of BMI1 was demonstrated to promote leukemic
transformation of human CD34
+ cells by BCR-ABL [11].
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36209However, the effects of overexpression of Bmi1 on hematopoiesis
remained to be precisely addressed.
In this study, we generated mice overexpressing Bmi1 in a
hematopoietic cell-specific manner. We analyzed the effects of
overexpression of Bmi1 on hematopoiesis under steady state
conditions as well as under multiple stresses. Our findings revealed
a protective function for Bmi1 in HSCs from stresses, such as
ROS, that usually limit the lifespan of HSCs.
Results
Generation of Mice Overexpressing Bmi1 in
Hematopoietic Cells
To generate tissue-specific Bmi1-transgenic mice, we knocked a
loxP-flanked neo
r-stop cassette followed by Flag-tagged Bmi1,a nfrt-
flanked IRES-eGFP cassette, and a bovine polyadenylation
sequence into the Rosa26 locus (Figure 1A). The obtained mice
(hereafter referred to as R26Stop
FLBmi1) were crossed with Tie2-Cre
mice [12] to drive Bmi1 expression in a hematopoietic cell-specific
manner. Quantitative RT-PCR analysis of bone marrow (BM)
Lineage marker
-Sca-1
+c-Kit
+ (LSK) cells confirmed 6-fold over-
expression of Bmi1 in Tie2-Cre;R26Stop
FLBmi1 mice compared to
the Tie2-Cre control mice (Figure 1B). Western blot analysis also
verified overexpression of Bmi1 protein in BM c-Kit
+ progenitor
cells from Tie2-Cre;R26Stop
FLBmi1 mice (Figure 1C).
Steady State Hematopoiesis in Tie2-Cre;R26Stop
FLBmi1
Mice
We first investigated the effect of overexpression of Bmi1 on
hematopoiesis in a steady state. Unexpectedly, 10-week-old Tie2-
Cre;R26Stop
FLBmi1 mice did not exhibit any significant differences
in the numbers of total BM cells, CD34
-LSK HSCs, LSK cells,
multipotent progenitors (MPPs), common myeloid progenitors
(CMPs), granulocyte/macrophage progenitors (GMPs), megakar-
yocyte/erythroid progenitors (MEPs), or common lymphoid
progenitors (CLPs) compared to the Tie2-Cre control mice
(Figure 1D and Figure S1A). The number of white blood cells
(WBC) in peripheral blood (PB) did not change upon forced
expression of Bmi1. Only the proportion of PB Gr-1
+/Mac-1
+
myeloid cells in Tie2-Cre;R26Stop
FLBmi1 mice was significantly
higher than in the control mice, although the difference was not
drastic (a difference of only about 2%) (Figure 1D). Furthermore,
Tie2-Cre;R26Stop
FLBmi1 mice did not show any significant differ-
ences in the numbers of total spleen cells, LSK cells in the spleen,
total thymic cells, or CD4
+CD8
-, CD4
-CD8
+, or CD4
+CD8
+ cells
in the thymus compared to the control mice (Figure S1A). These
findings indicate that overexpression of Bmi1 does not largely
compromise differentiation of HSCs. We further analyzed the cell
cycle status of CD34
-LSK HSCs by Pyronin Y staining, but again
did not detect any changes (Figure S1B). These results indicate
that overexpression of Bmi1 only slightly perturbs hematopoiesis
under steady state conditions, suggesting that the level of
endogenous Bmi1 is sufficient to repress the transcription of its
target genes.
Colony-forming Capacity of Hematopoietic Stem and
Progenitor Cells Overexpressing Bmi1
We next evaluated the proliferative and differentiation capacity
of Tie2-Cre;R26Stop
FLBmi1 HSCs in vitro. Single CD34
-LSK HSCs
were clonally sorted into 96-microtiter plates with the medium
supplemented with stem cell factor (SCF), thrombopoietin (TPO),
interleukin-3 (IL-3), and erythropoietin (EPO) and allowed to form
colonies. At day 14 of culture, the colonies were counted and
individually collected for morphological examination. Both Tie2-
Cre control and Tie2-Cre;R26Stop
FLBmi1 HSCs gave rise to
comparable numbers of high proliferative potential (HPP) and
low proliferative potential (LPP) colonies with a diameter greater
than and less than 1 mm, respectively (Figure 2A). The
morphological analysis of colonies revealed that the number of
colony-forming unit (CFU)-neutrophil/macrophage/erythroblast/
megakaryocyte (nmEM) was also comparable between the two
groups (Figure 2A). CFU-nmEM is a major subpopulation
among CD34
2LSK HSCs and its frequency is well correlated with
that of functional HSCs [13]. These findings indicate that
overexpression of Bmi1 in freshly isolated CD34
-LSK HSCs does
not affect their colony-forming capacity or differentiation in vitro.
We previously reported that overexpression of Bmi1 by
retroviral transduction efficiently maintains hematopoietic stem
and progenitor cells during long-term culture [7]. We re-evaluated
the effect of forced expression of Bmi1 using Tie2-Cre;R26-
Stop
FLBmi1 HSCs. CD34
-LSK cells were cultured for 10 days in
a serum-free medium supplemented with SCF and TPO, a
cytokine combination which supports the proliferation of HSCs
and progenitors rather than their differentiation [14]. Although
Tie2-Cre;R26Stop
FLBmi1 HSCs did not show any growth advantage
over the control (Figure 2B), the Tie2-Cre;R26Stop
FLBmi1 HSC
culture contained significantly more HPP-colony-forming cells
(CFCs) and CFU-nmEM than the control (Figure 2B). Corre-
spondingly, flow cytometric analysis revealed more LSK cells in
the Tie2-Cre;R26Stop
FLBmi1 HSC culture than in the control
culture at day 14 (Figure 2C). There was no significant difference
in the frequency of apoptotic cells between the control and Tie2-
Cre;R26Stop
FLBmi1 HSC cultures (Figure S2A). Of note, however,
the Tie2-Cre;R26Stop
FLBmi1 HSC culture contained a significantly
higher proportion of LSK cells in the G0/G1 stage of cell cycle
than the control (Figure S2B). These findings suggest that
overexpression of Bmi1 slows down cell cycle of immature
hematopoietic cells in culture, leading to no growth advantages
over the control cells in spite of an increase in immature
progenitors in culture. As we reported previously, the Ink4a/Arf
locus is a critical target of Bmi1 in HSCs [8]. Quantitative RT-
PCR confirmed that p19
Arf was closely repressed in transcription
upon Bmi1 overexpression (Figure 2D). These results support our
previous finding that HSCs overexpressing Bmi1 retain their self-
renewal capacity better than the control HSCs under the culture
stress.
Overexpression of Bmi1 Enhances Expansion of HSCs ex
vivo and Protects HSCs During Serial Transplantation
HSCs are exposed to oxidative stress during long-term culture
in 20% O2 [15]. In order to precisely determine the effect of
overexpression of Bmi1 on HSCs during culture, we next
determined the frequency of functional HSCs contained in
optimized serum-free culture by competitive repopulating unit
(CRU) assay. We first transplanted limiting doses of fresh
CD34
-LSK cells from Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice
along with 2610
5 competitor BM cells. The frequency of long-
term repopulating HSCs was 1 in 8 among fresh CD34
-LSK cells
from both Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice (Figure 3).
We then cultured CD34
-LSK cells for 10 days in a serum-free
medium supplemented with SCF and TPO in 20% O2. During
the 10-day culture period, functional HSCs increased 4-fold (1 out
of 2 CD34
-LSK cells) in control CD34
-LSK cells. Interestingly,
overexpression of Bmi1 established 2-fold better expansion of
HSCs than the control during culture ex vivo (Figure 3). These
findings are the first to show that Bmi1 has a role in the expansion
of HSCs.
Bmi1 Protects HSCs from Stresses
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36209HSCs are exposed to various stresses including replicative and
oxidative stresses during serial transplantation and eventually lose
self-renewal capacity [16,17]. We hypothesized that the effects of
overexpression of Bmi1 on HSCs would manifest under stressful
conditions such as serial transplantations. Therefore, we per-
formed competitive repopulation assays using 5610
5 fresh BM
Figure 1. Generation of mice overexpressing Bmi1 in hematopoietic cells. (A) Strategy for making a knock-in allele for Bmi1 downstream of
the Rosa26 promoter. A loxP-flanked neo
r-stop cassette followed by Flag-tagged Bmi1,a nfrt-flanked IRES-eGFP cassette, and a bovine polyadenylation
sequence was knocked-in the Rosa26 locus. (B) Quantitative RT-PCR analysis of Bmi1 in BM LSK cells from Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice.
mRNA levels were normalized to Hprt1 expression. Expression levels relative to that in Tie2-Cre LSK cells are shown as the mean 6 S.D. (n=3). (C)
Western blotting analysis of Bmi1 in c-Kit
+ BM cells from Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice. a-tubulin was used as the loading control. (D)
Hematopoietic analysis of 10-week-old Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice. Absolute numbers of BM cells, CD34
-LSK cells, and LSK cells in
bilateral femurs and tibiae are presented as the mean 6 S.D. (upper panels, Tie2-Cre;n=7 ,Tie2-Cre;R26Stop
FLBmi1; n=8). PB analysis of 10-week-old
Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice. White blood cell (WBC) counts and lineage contribution of myeloid, B, and T cells are shown as the mean 6
S.D. (lower panels, Tie2-Cre;n=7 ,Tie2-Cre;R26Stop
FLBmi1; n=8). ** p,0.01.
doi:10.1371/journal.pone.0036209.g001
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Figure 2. Effects of overexpression of Bmi1 on HSCs in vitro. (A) Colony formation by HSCs isolated from Tie2-Cre (Control) and Tie2-
Cre;R26Stop
FLBmi1 (Bmi1) mice. Single CD34
-LSK cells were sorted into 96-well microtiter plates containing the SF-O3 medium supplemented with
10% FBS and multiple cytokines (10 ng/ml SCF, 10 ng/ml TPO, 10 ng/ml IL-3, and 3 u/ml EPO) and allowed to form colonies. At day 14 of culture, the
colonies were counted and individually collected for morphological examination. Absolute numbers of LPP and HPP-CFCs which gave rise to colonies
with a diameter less and greater than 1 mm, respectively are shown as the mean 6 S.D. for triplicate cultures (left panel). Absolute numbers of each
Bmi1 Protects HSCs from Stresses
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36209cells along with 5610
5 competitor BM cells (Figure 4A) or the
total cells produced from 20 CD34
-LSK cells after a 10-day
culture period along with 2610
5 competitor BM cells (Figure 4B).
The flow cytometric analysis of PB revealed little or no difference
in the chimerism of donor cells between Tie2-Cre and Tie2-
Cre;R26Stop
FLBmi1 cells at 12 weeks after the primary transplan-
tations. However, in the secondary and tertiary transplantations,
the chimerism of Tie2-Cre cells significantly declined while that of
Tie2-Cre;R26Stop
FLBmi1 cells drasticaly increased. Tie2-Cre cells
after 10-day culture failed to reconstitute hematopoiesis in the
quaternary transplantation, while Tie2-Cre;R26Stop
FLBmi1 cells still
established robust repopulation (Figure 4B). The chimerism of
donor cells in BM LSK cells mirrored the changes in the PB.
These results clearly indicate that overexpression of Bmi1 protects
HSCs against the loss of self-renewal capacity during serial
transplantation. The findings thus far suggest that overexpression
of Bmi1 confers stress resistance onto HSCs.
colony types were defined by the composition of colonies (right panel). Colonies were recovered and examined by microscopy to determine colony
types. Composition of colonies is depicted as n, neutrophils; m, macrophages; E, erythroblasts; and M, megakaryocytes. (B) Colony formation by HSCs
cultured for 10 days. CD34
-LSK cells from Tie2-Cre (Control) and Tie2-Cre;R26Stop
FLBmi1 (Bmi1) mice were cultured in the SF-O3 serum-free medium
supplemented with 50 ng/ml of SCF and TPO. At day 10 of culture, the cells were counted (left panel) and plated in methylcellulose medium to allow
formation of colonies in the presence of 20 ng/ml SCF, 20 ng/ml TPO, 20 ng/ml IL-3, and 3 u/ml EPO. Absolute numbers of LPP and HPP-CFCs
(middle panel) are shown as the mean 6 S.D. for triplicate cultures. Absolute numbers of each colony type are shown in the right panel. (C) Flow
cytometric analysis of CD34
-LSK HSCs at day14 of culture. Representative flow cytometric profiles of LSK cells in cultures of CD34
-LSK HSCs from Tie2-
Cre (Control) and Tie2-Cre;R26Stop
FLBmi1 (Bmi1) mice are depicted. The proportion of Lin
- and LSK cells in total cells are indicated. (D) Quantitative RT-
PCR analysis of the expression of p19
Arf, and Bmi1 in Tie2-Cre (Control) and Tie2-Cre;R26Stop
FLBmi1 (Bmi1) LSK cells. LSK cells were purified by cell
sorting from CD34
-LSK cultures in (C) at day 14 of culture. Each value was normalized to Hprt1 expression and the expression level of each gene in
control cells was arbitrarily set to 1. Data are shown as the mean 6 S.D. for triplicate analyses. * p,0.05, **p,0.01.
doi:10.1371/journal.pone.0036209.g002
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Figure 3. Overexpression of Bmi1 enhances expansion of HSCs ex vivo. Competitive repopulating unit (CRU) assays using limiting numbers
of CD34
-LSK cells from Tie2-Cre (Control) mice and Tie2-Cre;R26Stop
FLBmi1 (Bmi1) mice. Freshly isolated CD34
-LSK cells were immediately used for BM
transplantation, or CD34
-LSK cells were cultured in the SF-O3 serum-free medium supplemented with 50 ng/ml SCF and TPO for 10 days, and then a
fraction of the culture cells corresponding to the indicated number (0.5,10) of initial CD34
-LSK cells was subjected to BM transplantation. The test
cells (CD45.2) were transplanted along with 2610
5 competitor BM cells (CD45.1) into CD45.1 recipient mice lethally irradiated at a dose of 9.5 Gy.
Percent chimerism of donor cells in the recipient PB was determined at 16 weeks after transplantation. The mice with chimerism more than 1% in all
three lineages (myeloid, B, and T cells) were considered successfully engrafted and the others were defined as negative mice. The frequency of HSCs
was calculated using L-Calc software. The proportion of engrafted mice, frequency of functional HSCs, and the 95% confidence interval (CI) are
summarized in the table and each data is plotted in the bottom panel. *** p,0.001.
doi:10.1371/journal.pone.0036209.g003
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Radioprotection
DNA damage is intimately linked to stem cell aging. Heritable
DNA damage accrued in stem cells leads to stem cell senescence or
apoptosis, which over time can lead to the depletion of the stem
cell pool and reduced regenerative capacity of stem cells [18].
Bmi1 is rapidly recruited to sites of DNA damage and is required
for DNA damage-induced ubiquitination of histone H2A at lysine
119. Loss of Bmi1 leads to impaired repair of DNA double-strand
breaks (DSBs) by homologous recombination [19,20]. In glioblas-
toma multiforme (GBM) cells, Bmi1 was co-purified with DSB
response proteins, such as ATM and the histone cH2AX, and
non-homologous end joining (NHEJ) repair proteins. Of interest,
BMI1 overexpression in normal neural stem cells enhanced ATM
recruitment to the chromatin, the rate of cH2AX foci resolution,
and resistance to radiation [21]. In order to understand the role of
overexpressed Bmi1 in HSCs, we examined the radioresistance of
HSCs by quantifying the number of cH2AX foci following
genotoxic stress, a metric which reflects DNA DSBs.
We purified CD34
-LSK cells from Tie2-Cre and Tie2-Cre;R26-
Stop
FLBmi1 mice and irradiated them at a dose of 2 Gy. At 2 and 4
hours after irradiation, cells were stained with anti-cH2AX. We
expected rapid resolution of cH2AX by overexpression of Bmi1,
but no significant difference was observed in the number of
cH2AX foci between Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 HSCs
(Figure 5A). HSCs recovered from the recipients of tertiary
transplantation did not show any difference in the number of
cH2AX foci, either (Figure 5B). We then tested hematopoietic
recovery after irradiation in mice. We irradiated recipient mice
reconstituted with Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 BM cells
at a dose of 5 Gy, and monitored hematopoietic recovery for 4
weeks. The recovery of hematopoietic components in PB as well as
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Figure 4. Overexpression of Bmi1 protects HSCs during serial transplantation. (A) Serial transplantation of BM cells. BM cells (5610
5) from
Tie2-Cre (denoted as ‘‘C’’) and Tie2-Cre;R26Stop
FLBmi1 (denoted as ‘‘B’’) mice (CD45.2) along with 5610
5 competitor BM cells (CD45.2) were
transplanted into CD45.1 recipient mice lethally irradiated at a dose of 9.5 Gy. For serial transplantation, BM cells were collected from all recipient
mice at 12–20 weeks after transplantation and pooled together. Then, 5610
6 BM cells were transplanted into lethally irradiated recipient mice
without competitor cells. Third and fourth transplantation were similarly performed using 5610
6 pooled BM cells. Percent chimerism of donor cells in
the recipient PB and BM LSK cells was determined at 16 weeks post-transplantation. Results are shown as the mean 6 S.D. (n=6, 3
rd transplantation;
n=4). (B) Serial transplantation of cultured CD34
-LSK cells. CD34
-LSK cells were cultured in the SF-O3 serum-free medium supplemented with 50 ng/
ml of SCF and TPO for 10 days. Then, the cells in culture corresponding to the 20 initial CD34
-LSK cells were injected into a recipient mouse along
with 2610
5 competitor BM cells (CD45.2) as described in (A) (n=6, 4
th transplantation; n=5). * P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0036209.g004
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S3). These findings suggest that overexpression of Bmi1 does not
afford an advantage to HSCs in their ability to resist genotoxic
stress.
Overexpression of Bmi1 Confers Resistance to Oxidative
Stress on HSCs
HSCs contain lower levels of reactive oxygen species (ROS)
than their mature progeny in order to maintain their quiescent
state. ROS reportedly act through p38 mitogen-activated protein
kinase (MAPK) to limit the lifespan of HSCs [16,22]. It has been
demonstrated that prolonged treatment with the antioxidant N-
acetyl-L-cysteine (NAC) or an inhibitor of p38 MAPK extends the
lifespan of HSCs in serial transplantation assays, suggesting that
oxidative stress is one of the major factors that affects HSC
function during these assays [16,17,23]. Given that Tie2-Cre;R26-
Stop
FLBmi1 HSCs retain self-renewal capacity during serial
transplantation, overexpression of Bmi1 may bestow a protective
effect onto HSCs against oxidative stress.
To address this question, we cultured HSCs in the presence of
buthionine sulfoximine (BSO), which depletes intracellular gluta-
thione and thereby increases intracellular ROS levels. We found
that highly purified CD34
-LSK HSCs were susceptible to an
increase in ROS levels because treatment with BSO significantly
suppressed their growth and induced cell death (data not shown).
After 3 days of BSO treatment, surviving cells were subjected to
colony-forming assays. Both Tie2-Cre control and Tie2-Cre;R26-
Stop
FLBmi1 HSCs cultured with BSO gave rise to significantly
fewer colonies than HSCs cultured without BSO. Interestingly,
Tie2-Cre;R26Stop
FLBmi1 HSCs gave rise to a significantly more
colonies than the control HSCs (Figure 6A). Notably, the number
of HPP colonies was reduced 48-fold after treatment of control
HSCs with BSO, but only 3-fold upon overexpression of Bmi1.
The frequency of CFU-nmEM was also less perturbed following
treatment with BSO in HSCs overexpressing Bmi1. These results
indicate a role for Bmi1 in the resistance to oxidative stress.
Bmi1 regulates mitochondrial function by regulating the
expression of a cohort of genes related to mitochondrial function
and ROS generation. Bmi1-deficient cells have impaired mito-
chondrial function, which causes a marked increase in the
intracellular levels of ROS [24]. Based on these observations, we
then measured the intracellular ROS levels in CD34
-LSK cells at
day 14 of culture. Unexpectedly, overexpression of Bmi1 did not
affect the levels of ROS in either LSK HSCs/MPPs or Lin
-Sca-
1
low/2c-Kit
+ downstream progenitors (Figure 6B). Overexpres-
sion of Bmi1 had no significant effect on the ROS levels even in the
presence of BSO (Figure S4). Likewise, treatment of cells with the
antioxidant NAC promoted cell growth and increased the
proportion of LSK cells in both control and Tie2-Cre;R26-
Stop
FLBmi1 culture similarly (Figure 6C and data not shown).
These results indicate that an excess of Bmi1 does not regulate the
generation or scavenging of ROS, but confers resistance to higher
levels of ROS on HSCs through unknown mechanisms.
Discussion
In this study, we generated a new mouse line where Bmi1 can be
conditionally overexpressed in a hematopoietic cell-specific fashion
and analyzed the effect of overexpression of Bmi1 in detail.
Overexpression of Bmi1 did not significantly affect steady state
hematopoiesis, but it efficiently protected HSCs from stresses. Our
findings suggest that overexpression of Bmi1 confers resistance to
stresses on HSCs, thereby augmenting their regenerative capacity.
Recent findings have established that the regulation of oxidative
stress in HSCs is critical for the maintenance of HSCs. In this
study, we demonstrated that overexpression of Bmi1 protects
HSCs from loss of self-renewal capacity at least in part by
increasing the capacity of HSCs to resist oxidative stress. It has
been reported that Bmi1-deficient mice have an increased level of
intracellular ROS due to de-regulated expression of genes related
to mitochondrial function and ROS generation [24,25]. However,
an excess of Bmi1 in this study had no effect on the levels of
intracellular ROS. Thus, it is hypothesized that Bmi1 is negatively
regulated downstream of the ROS signal and an excess of Bmi1
overcomes this negative regulation. Indeed, ROS reportedly
primes Drosophila hematopoietic progenitors for differentiation
and this process involves downregulation of PcG activity [26].
ROS signaling activates p38 and eventually releases the transcrip-
tional repression of p16
Ink4a and p19
Arf, critical targets of Bmi1
[16]. Furthermore, recent studies including ours have revealed
that PcG proteins are downregulated and dissociate from the
Ink4a/Arf locus when cells are exposed to intra- or extracellular
stress, including tissue culture- and oncogene-induced stress
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is dynamically regulated in response to oxidative stress, probably
downstream of p38. Our preliminary data demonstrated that
activated p38 directly phosphorylates Bmi1 in vitro (Oshima and
Iwama., unpublished data). Thus, it is possible that p38, which is
activated by oxidative stress, attenuates Bmi1 function via direct
phosphorylation of Bmi1. How oxidative stress restricts the
expression and function of Bmi1 is an important issue to be
addressed.
Of note, the effect of Bmi1 overexpression in serial transplan-
tation resembles that of overexpression of Ezh2, a gene encoding a
core component of PRC2 [29]. Overexpression of PcG genes,
Bmi1 and Scmh1, also induces tolerance of cortical neurons to
ischemia [30]. Thus, various cellular stresses may target PcG
complexes to release transcriptional repression of PcG-regulated
genes, such as tumor suppressor and developmental regulator
genes, thereby affecting stemness. All these findings support the
notion that enforcement of PcG function is a key for successful
regenerative therapies.
Meanwhile, the role of PcG proteins in resistance to oxidative
stress is also implicated in cancer. Expression of PcG proteins
including BMI1 and EZH2 are often up-regulated in various
cancers, particularly in their cancer stem cell fractions [31].
Interestingly, cancer stem cells in some tumors appear to be
susceptible to ROS, similar to normal stem cells, and thus develop
mechanisms to keep the levels of ROS low [32]. Interference of
EZH2 function by the small-molecule histone methyltransferases
inhibitor, DZNep, is reported to increase ROS levels in acute
myeloid leukemia cells like in Bmi1-deficient mice [33]. Converse-
ly, our findings in this study suggest that an excess of PcG proteins
often observed in aggressive cancer could help cancer stem cells
tolerate oxidative stress. In this regard, overexpression of PcG
proteins could also be therapeutic targets in cancers including
leukemia. Finally, no Tie2-Cre;R26Stop
FLBmi1 mice developed
hematological malignancies during the observation period, up to
18 months after birth. Only one recipient mice with Tie2-
Cre;R26Stop
FLBmi1 BM cells developed acute lymphocytic leuke-
mia in the tertiary transplantation. These findings suggest that
Bmi1 by itself is not sufficient to induce hematological malignan-
cies.
Methods
Ethics Statement
All experiments using the mice were performed in accordance
with our institutional guidelines for the use of laboratory animals
and approved by the review board for animal experiments of
Chiba University (approval ID: 21–150).
Generation of Mice
To generate tissue-specific Bmi1-transgenic mice, we used the
plasmid R26Stop
FL, a modified version of pROSA26-1 with a loxP-
flanked neo
r-stop cassette, an frt-flanked IRES-eGFP cassette, and a
bovine polyadenylation sequence [34]. We cloned a cDNA
encoding a flag-tagged Bmi1 upstream of the IRES sequence
(R26Stop
FLBmi1). R1 ES cells were transfected, cultured, and
selected as previously described [35]. For conditional expression of
Bmi1, the RosaStop
FLBmi1 mice were crossed with Tie2-Cre mice.
C57BL/6 (CD45.2) mice were purchased from Japan SLC
(Shizuoka, Japan). C57BL/6 mice congenic for the Ly5 locus
(CD45.1) were purchased from Sankyo-Lab Service (Tsukuba,
Japan). Mice were bred and maintained in the Animal Research
Facility of the Graduate School of Medicine, Chiba University in
accordance with institutional guidelines. This study was approved
by the institutional review committees of Chiba University
(approval numbers 21–65 and 21–150).
Flow Cytometric Analysis and Cell Sorting
Mouse CD34
–LSK HSCs were purified from BM of 8–12-
week-old mice. Mononuclear cells were isolated on Ficoll-Paque
PLUS (GE Healthcare). Cells were stained with an antibody
cocktail consisting of biotinylated anti-Gr-1, Mac-1, interleukin
(IL)-7Ra, B220, CD4, CD8a, and Ter119 monoclonal antibodies.
The monoclonal antibodies were purchased from eBioScience or
BioLegend. Lineage-positive cells were depleted with goat anti-rat
IgG microbeads (Miltenyi Biotec) through an LS column (Miltenyi
Biotec). Cells were further stained with Alexa FluorH 647 or
eFluorH 660-conjugated anti-CD34, phycoerythrin (PE)-conjugat-
ed anti-Sca-1, and phycoerythrin/Cy7 (PE/Cy7)-conjugated anti-
c-Kit antibodies. Biotinylated antibodies were detected with
allophycocyanin/Cy7 (APC/Cy7)-conjugated streptavidin. Dead
cells were eliminated by staining with Propidium iodide (1 mg/ml,
Sigma). Analysis and sorting were performed on a FACS Aria II
(BD Bioscience).
Cell Cycle Analysis
Fresh BM cells (1610
7, CD45.2) were transplanted into 8-week-
old CD45.1 mice irradiated at a dose of 9.5 Gy without
competitor cells. Four months later, BM mononuclear cells were
isolated on Ficoll-Paque PLUS. Cells were stained with an
antibody cocktail consisting of biotinylated anti-Gr-1, Mac-1, IL-
7Ra, B220, CD4, CD8a, Ter119, and CD45.1 monoclonal
antibodies. Cells were further stained with Alexa FluorH 700-
conjugated anti-CD34, pacific blue-conjugated anti-Sca-1, and
APC-conjugated anti-c-Kit antibodies. Biotinylated antibodies
were detected with APC/Cy7-conjugated streptavidin. Analysis
was performed on a FACS Aria II. To analyze the cell-cycle status,
cells were incubated with 1 mg/ml Pyronin Y (Sigma) at 37uC for
45 min with protection from light. Bulk sorted CD34
-LSK cells
were incubated in SF-O3 supplemented with 50 mM?2-b-mercap-
toethanol, 0.2% BSA, 1% GPS, 50 ng/ml SCF, 50 ng/ml TPO
for 10 days at 37uC in a 5% CO2 atmosphere. At day 10 of
culture, the cell cycle profiles of culture cells were analyzed using
an APC BrdU Flow Kit (BD Pharmingen). The cells were
incubated with 10 mM BrdU at 37uC for 30 min and then stained
with an antibody cocktail consisting of biotinylated anti-Gr-1,
Figure 6. Overexpression of Bmi1 confers oxidative stress on HSCs. (A) Colony formation by HSCs cultured for 3 days. CD34
-LSK cells from
Tie2-Cre (Control) and Tie2-Cre;R26Stop
FLBmi1 (Bmi1) mice were cultured in the SF-O3 serum-free medium supplemented with 50 ng/ml SCF, TPO and
0.05 mM of BSO. At day 3 of culture, the cells were plated in methylcellulose medium to allow formation of colonies in the presence of 20 ng/ml SCF,
20 ng/ml TPO, 20 ng/ml IL-3, and 3 u/ml EPO. Absolute numbers of LPP and HPP-CFCs (left panel) are shown as the mean 6 S.D. for triplicate
cultures. Absolute numbers of each colony types are shown in the right panel. Data are shown as the mean 6 S.D. for triplicate analyses. Statistical
analyses were performed on the total colony numbers (left panel) and nmEM colony numbers (right panel), respectively. **p,0.01. (B) Levels of ROS
in cells overexpressing Bmi1. CD34
-LSK cells from Tie2-Cre (Control) and Tie2-Cre;R26Stop
FLBmi1 (Bmi1) mice were cultured in the SF-O3 serum-free
medium supplemented with 50 ng/ml SCF and TPO. Representative flow cytometric profiles of LSK and Lineage marker
-Sca-1
low/2c-Kit
+ cells in
cultures at day 14 are depicted. (C) Effects of NAC on Bmi1 culture. CD34
-LSK cells from Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice were cultured in the
SF-O3 serum-free medium supplemented with 50 ng/ml SCF and TPO in the presence and absence of 150 mM NAC. Representative flow cytometric
profiles of LSK cells in cultures at day 14 are depicted. The proportion of Lin
- and LSK cells in total cells are indicated.
doi:10.1371/journal.pone.0036209.g006
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antibodies. Cells were further stained with PE-conjugated anti-
Sca-1, and PE/Cy7-conjugated anti-c-Kit antibodies. Biotinylated
antibodies were detected with APC/Cy7-conjugated streptavidin.
Analysis was performed on a FACS Canto II (BD Bioscience).
Colony Assay
Colony assays were performed in methylcellulose-containing
Iscove’s modified Dulbecco’s medium (Methocult M3234; Stem-
cell Technologies) supplemented with 20 ng/ml mouse SCF,
20 ng/ml mouse IL-3, 20 ng/ml human TPO, and 3 U/ml
human EPO (Peprotech), and incubated at 37uC in a 5% CO2
atmosphere. The number of HPP- and LPP-colony-forming cells
(CFCs), which generate a colony with a diameter $1 mm and
,1 mm, respectively, were evaluated by counting colonies at day
10–14 of culture. Colonies were individually collected, cytospun
onto glass slides, and subjected to Hemacolor (MERCK) staining
for morphological examination. To evaluate the proliferative and
differentiation capacity of Tie2-Cre;R26Stop
FLBmi1 HSCs in vitro,
single CD34
-LSK HSCs were clonally sorted into 96-microtiter
plates containing 100 ml SF-O3 (Sanko Junyaku) supplemented
with 50 mM2 - b-mercaptoethanol, 10% FBS, 1% L-glutamine,
penicillin, streptomycin solution (GPS; Sigma), 10 ng/ml mouse
SCF, 10 ng/ml human TPO, 10 ng/ml mouse IL-3, and 3 unit/
ml human EPO (PeproTech). At day 14 of culture, the colonies
were counted and individually collected for morphological
examination. To evaluate the tolerance of test cells against
oxidative stress, CD34
-LSK cells were cultured in the presence of
DL-Buthionin-(S,R)-sulfoximine (BSO, Sigma) or N-Acetyl-L-cys-
teine (NAC, Sigma) for the indicated time periods, then subjected
to colony assays or flow cytometric analyses.
Serial Transplantation and CRU Assays
Fresh BM cells (5610
5, CD45.2) or 10-day cultured CD34
-LSK
cells (CD45.2) corresponding to 20 initial CD34
-LSK cells were
transplanted into 8-week-old recipient mice (CD45.1) irradiated at
a dose of 9.5 Gy together with 5610
5 and 2610
5 BM competitor
cells from 8-week-old CD45.1 mice, respectively. For serial
transplantation, BM cells were collected from all recipient mice
at 12–20 weeks after transplantation and pooled together. Then,
5610
6 BM cells were transplanted into 8-week-old B6-CD45.1
mice irradiated at a dose of 9.5 Gy without competitor cells. Third
and fourth transplantation were similarly performed using 5610
6
pooled BM cells. Peripheral blood (PB) cells of the recipient mice
were analyzed with a mixture of antibodies that included PE/Cy7-
conjugated anti-CD45.1, pacific blue-conjugated anti-CD45.2,
PE-conjugated anti-Mac-1 and anti-Gr-1, APC-conjugated anti-
B220, and APC/Cy7-conjugated anti-CD4 and anti-CD8a
antibodies. Cells were analyzed on a FACS Canto II. Percent
donor chimerism was calculated as (% donor cells) 6100/(%
donor cells + % recipient cells). To obtain the competitive
repopulating units (CRUs), CRU assays were performed with a
limiting number of test cells and the data were analyzed using L-
Calc software (StemCell Technologies). Peripheral blood cell
counts were made using an automated cell counter, Celltec a
(Nihon Kohden).
Apoptosis Analysis
Bulk sorted CD34
-LSK cells were incubated in SF-O3
supplemented with 50 mM?2-b-mercaptoethanol, 0.2% BSA, 1%
GPS, 50 ng/ml SCF, 50 ng/ml TPO for 10 days at 37uCi na5 %
CO2 atmosphere. At day 10 of culture, the cultured cells were
incubated with APC-conjugated anti-Annexin V (BD Pharmingen)
and propidium iodide at room temperature for 15 min with
protection from light. Analysis was performed on FACS Canto II.
Immunostaining of cH2A.X
Cells were incubated in a culture medium drop on slide glasses
pre-treated with poly-L-lysine (Sigma) for 2 hours. After fixation
with 2% paraformaldehyde and blocking in 4% sheep serum for
30 min at room temperature, cells were incubated with purified
anti-phospho-Histone H2A.X (Ser139) antibody (Cell Signaling
Technology) for 12 hours at 4uC. The cells were then washed and
incubated with Alexa Flour 555-conjugated anti-rabbit IgG goat
polyclonal antibody (Invitrogen) for 60 min at room temperature.
DNA was counterstained with 49,6-diamidino-2-phenylindole
(DAPI). Images were taken with a Keyence BZ-9000 fluorescence
microscope.
RT-PCR
Total RNA was isolated using TRIZOL LS solution or
TRIZOL solution (Invitrogen) and reverse transcribed by the
ThermoScript RT-PCR system (Invitrogen) with an oligo-dT
primer. Real-time quantitative polymerase chain reaction (PCR)
was performed with an ABI prism 7300 Thermal Cycler (Applied
Biosystems) using FastStart Universal Probe Master (Roche). The
combination of primer sequences and probe numbers are as
follows: for p16
Ink4a, probe #91, 59-AATCTCCGCGAGGA-
AAGC-39, and 59-GTCTGTCTGCAGCGGACTC-39; for
p19
Arf, probe #106, 59-GGGTTTTCTTGGTGAAGTTCG-39,
59- TTGCCCATCATCATCACCT-39, and for Bmi1, probe #95,
59-AAACCAGACCACTCCTGAACA-39 and 59-TCTTCTT-
CTCTTCATCTCATTTTTGA-39.
Western Blotting
Total cell lysate was resolved by SDS-PAGE and transferred to
a PVDF membrane. The blots were probed with a mouse anti-
Bmi1 (clone 8A9, kindly provided by Dr. N. Nozaki, MAB
Institute, Co. Ltd., Japan), and a horseradish peroxidase-conju-
gated secondary antibody. The protein bands were detected with
an enhanced chemiluminescence reagent (SuperSignal, Pierce
Biotechnology).
Detection of ROS
Cells were stained with an antibody cocktail consisting of
biotinylated anti-Gr-1, Mac-1, IL-7Ra, B220, CD4, CD8a, and
Ter119 monoclonal antibodies. Cells were further stained with
PE-conjugated anti-Sca-1, and PE/Cy7-conjugated anti-c-Kit
antibodies. Biotinylated antibodies were detected with APC/
Cy7-conjugated streptavidin. After staining with antibodies, cells
were incubated with CellROX
TM Deep Red Reagent (5 mM,
Invitrogen) at 37uC for 30 min with protection from light. Dead
cells were eliminated by staining with propidium iodide (1 mg/ml,
Sigma). Analysis was performed on a FACS Aria II.
Supporting Information
Figure S1 Steady state hematopoiesis in Tie2-Cre;R26-
StopFLBmi1 mice. (A) Hematopoietic analysis of 10-week-old
Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice. Absolute numbers of
CMPs, GMPs, MEPs, and CLPs in bilateral femurs and tibiae
(upper panels), total spleen cells and LSK cells in the spleen
(middle panel), and total thymic cells, CD4+CD8- cells, CD4-
CD8+ cells, and CD4+CD8+ cells in the thymus (lower panels) are
shown as the mean 6 S.D. (Tie2-Cre;n = 8 ,Tie2-Cre;R26-
Stop
FLBmi1; n=7). (B) Cell cycle status of CD34-LSK cells
examined by Pyronin Y incorporation. Proportion of CD34-
Bmi1 Protects HSCs from Stresses
PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e36209LSK cells in the G0 phase of the cell cycle (Pyronin Y-) was shown
as the mean 6 S.D. (n=4) (left panel). Representative flow
cytometric profiles are also depicted (right panel).
(EPS)
Figure S2 Apoptosis and cell cycle status of Tie2-
Cre;R26Stop
FLBmi1 LSK cells in culture. (A) The proportion
of apoptotic cells in the LSK fraction in culture. CD34-LSK cells
from Tie2-Cre (Control) and Tie2-Cre;R26Stop
FLBmi1 (Bmi1) mice
were cultured in the SF-O3 serum-free medium supplemented
with 50 ng/ml SCF and TPO. At day 10 of culture, apoptotic cells
were detected by staining culture cells with anti-Annexin V and
propidium iodide (PI). The percentage of Annexin V+PI-
apoptotic cells in the LSK fraction is shown as the mean 6 S.D.
(n=5). (B) The cell cycle status of LSK cells overexpressing Bmi1.
CD34-LSK cells from Tie2-Cre (Control) and Tie2-Cre;R26-
Stop
FLBmi1 (Bmi1) mice were cultured in the SF-O3 serum-free
medium supplemented with 50 ng/ml SCF and TPO. At day 10
of culture, the cells were incubated with 10 mM BrdU at 37uC for
30 min and then analyzed using a BrdU Flow Kit. Data are shown
as the mean 6 SD (n=4).
(EPS)
Figure S3 Hematopoietic recovery in recipients of Tie2-
Cre;R26Stop
FLBmi1 HSCs after irradiation. Fresh BM cells
from Tie2-Cre and Tie2-Cre;R26Stop
FLBmi1 mice (16107, CD45.2)
were transplanted into 8-week-old CD45.1 mice irradiated at a
dose of 9.5 Gy without competitor cells. Four months later, the
recipient mice were irradiated at a dose of 5 Gy. Changes in the
PB cell count were monitored for 4 weeks (A) and the absolute
number of BM LSK cells in bilateral femurs and tibiae was
examined at 4 weeks post-irradiation (B). Data are shown as the
mean 6 SD (n=5).
(EPS)
Figure S4 ROS levels in Tie2-Cre;R26Stop
FLBmi1 cells in
culture. Levels of ROS in cells overexpressing Bmi1 in culture.
CD34-LSK cells from Tie2-Cre (Control) and Tie2-Cre;R26-
Stop
FLBmi1 (Bmi1) mice were cultured in the SF-O3 serum-free
medium supplemented with 50 ng/ml SCF and TPO. Cells from
day 11 or 12 of culture were further cultured for 2 days in the
presence of 0.2 mM BSO, then levels of ROS in Lin-Sca-1+c-Kit+
cells and Lin-Sca-1low/2c-Kit+ cells were analyzed using
CellROXTM Deep Red Reagent. Data are shown as dots and
the mean values are indicated by bars (n=4).
(EPS)
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